Skip to main content

Mark Roellig, Philip Needleman, and August Watanabe

Premium

Fisher Scientific said last week that Mark Roellig has joined the company as vice president, general counsel, and secretary.

According to Fisher, Roellig previously served as vice president, general counsel, and secretary of Storage Technology, where he was responsible for all legal and public-policy issues as well as supporting the activities of the board of directors.

Prior to this, Roellig served in legal positions for US West, and practiced civil litigation for Seattle-based law firms Reed, McClure, Moceri, and Thonn; and Perey and Smith.

Roellig has a BS in mathematics from the University of Michigan, and a law degree from George Washington University. He also holds an MBA from the University of Washington in Seattle.


Kalypsys said last week that it has appointed Philip Needleman and August Watanabe to its board of directors.

Needleman most recently served as senior executive vice president of Pharmacia, where he has also held positions as chief scientist and chairman of research and development. Prior to this, he served as president of Searle Research and Development and senior vice president of Monsanto. He spent 25 years as professor and chairman of the department of pharmacology at Washington University School of Medicine.

Watanabe is a former senior executive at Eli Lilly, where he served 13 years in positions such as executive vice president of science and technology, president of Lilly Research Laboratories, and as a member of the board of directors. Prior to this, he was a faculty member at the department of internal medicine at the Indiana School of Medicine for 18 years.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.